Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kanha Life Science is an Indian pharmaceutical company primarily engaged in the development, manufacture, and export of Active Pharmaceutical Ingredients (APIs) and advanced drug intermediates. Based in Gujarat, the company operates a state-of-the-art manufacturing facility that adheres to Good Manufacturing Practices (GMP) to serve the global generic pharmaceutical market. Their product portfolio focuses on high-growth therapeutic areas including antidiabetics, cardiovascular agents, and central nervous system treatments. In addition to catalog products, Kanha Life Science provides contract manufacturing and custom synthesis services for complex organic molecules. The company is recognized for its expertise in multi-step chemical synthesis and its ability to scale production from laboratory to commercial volumes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kanha Life Science.